77 related articles for article (PubMed ID: 8113903)
1. Technetium-99m-pertechnetate as a whole blood marker for brain perfusion studies.
Keyeux AJ; Ochrymowicz-Bemelmans DA; Charlier AA
J Nucl Med; 1994 Mar; 35(3):479-83. PubMed ID: 8113903
[TBL] [Abstract][Full Text] [Related]
2. Early behaviour of 99mTc-pertechnetate in the head after intravenous bolus injection: its relevance to the cerebral blood circulation.
Keyeux A; Ochrymowicz-Bemelmans D
Eur J Nucl Med; 1983; 8(5):196-200. PubMed ID: 6307699
[TBL] [Abstract][Full Text] [Related]
3. Total cerebral blood volume calculated from a model of [99mTc]pertechnetate distribution in the head.
Keyeux A; Ochrymowicz-Bemelmans D; Van Eyll C; Charlier AA
J Appl Physiol (1985); 1993 Jun; 74(6):2886-95. PubMed ID: 8396111
[TBL] [Abstract][Full Text] [Related]
4. Regional brain hematocrit in stroke by single photon emission computed tomography imaging.
Loutfi I; Frackowiak RS; Myers MJ; Lavender JP
Am J Physiol Imaging; 1987; 2(1):10-6. PubMed ID: 3502527
[TBL] [Abstract][Full Text] [Related]
5. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell labelling by intravenous injection of 99mTc-PAEP.
Varvarigou A; Chiotellis E; Vavouraki H
Nuklearmedizin; 1984 Feb; 23(1):29-30. PubMed ID: 6328452
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-N1-(2-mercapto-2-methylpropyl)-N2-(2-propargylthio-2- methylpropyl)-1,2-benzenediamine (T691): preclinical studies of a potential new tracer of regional cerebral perfusion.
Taylor SF; Frey KA; Baldwin RM; Papadopoulos SM; Petry NA; Rogers WL; McBride BJ; Kerr JM; Kuhl DE
J Nucl Med; 1992 Oct; 33(10):1836-42. PubMed ID: 1403153
[TBL] [Abstract][Full Text] [Related]
8. A neutral lipophilic technetium-99m complex for regional cerebral blood flow imaging.
Narra RK; Nunn AD; Kuczynski BL; DiRocco RJ; Feld T; Silva DA; Eckelman WC
J Nucl Med; 1990 Aug; 31(8):1370-7. PubMed ID: 2384806
[TBL] [Abstract][Full Text] [Related]
9. A developmental analysis of differences in the uptake of [123I]isopropyliodoamphetamine versus 99mTc-pertechnetate by the choroid plexus and brain.
Yacavone RF; Dyas ML; Johanson CE
Neurochem Res; 1994 Apr; 19(4):379-84. PubMed ID: 8065493
[TBL] [Abstract][Full Text] [Related]
10. Relationships between moment of monitored time-activity curves and regional cerebral mean transit time following common carotid administration of a non diffusible tracer.
Bartolini A; Leonardi A; Albano A; Primavera A
Boll Soc Ital Biol Sper; 1983 Jan; 59(2):131-4. PubMed ID: 6305377
[TBL] [Abstract][Full Text] [Related]
11. Parametric imaging of cerebral vascular reserves. 1. Theory, validation and normal values.
Merrick MV; Ferrington CM; Cowen SJ
Eur J Nucl Med; 1991; 18(3):171-7. PubMed ID: 1645663
[TBL] [Abstract][Full Text] [Related]
12. Extravasation of pertechnetate in cranial extracerebral tissues during first pass across the cerebral vasculature.
Bartolini A; Leonardi A; Albano A; Primavera A
Boll Soc Ital Biol Sper; 1983 Jan; 59(2):126-30. PubMed ID: 6305376
[TBL] [Abstract][Full Text] [Related]
13. Design, preparation, and biodistribution of a technetium-99m triaminedithiol complex to assess regional cerebral blood flow.
Lever SZ; Burns HD; Kervitsky TM; Goldfarb HW; Woo DV; Wong DF; Epps LA; Kramer AV; Wagner HN
J Nucl Med; 1985 Nov; 26(11):1287-94. PubMed ID: 4056926
[TBL] [Abstract][Full Text] [Related]
14. Elimination of extracranial blood flow during dynamic cerebral perfusion studies using diffusible and non-diffusible radioisotope.
Ahonen A; Koivula A; Kallanranta T; Kuikka J
Acta Neurol Scand; 1981 Dec; 64(6):394-400. PubMed ID: 7347998
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
Andersen AR
Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
[TBL] [Abstract][Full Text] [Related]
16. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates.
Walovitch RC; Hill TC; Garrity ST; Cheesman EH; Burgess BA; O'Leary DH; Watson AD; Ganey MV; Morgan RA; Williams SJ
J Nucl Med; 1989 Nov; 30(11):1892-901. PubMed ID: 2809756
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m bis (aminoethanethiol) complexes with amine sidechains--potential brain perfusion imaging agents for SPECT.
Efange SM; Kung HF; Billings J; Guo YZ; Blau M
J Nucl Med; 1987 Jun; 28(6):1012-9. PubMed ID: 3108466
[TBL] [Abstract][Full Text] [Related]
18. Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography.
Hambÿe AS; Verbeke KA; Vandermeiren RP; Joosens EJ; Verbruggen AM; De Roo MJ
J Nucl Med; 1997 Oct; 38(10):1521-8. PubMed ID: 9379186
[TBL] [Abstract][Full Text] [Related]
19. Limitations to effect of alpha-MSH on permeability of blood-brain barrier to IV 99mTc-pertechnetate.
Kastin AJ; Fabre LA
Pharmacol Biochem Behav; 1982 Dec; 17(6):1199-201. PubMed ID: 6298832
[TBL] [Abstract][Full Text] [Related]
20. Radionuclide venography: two stage--flow and equilibrium technique using 99mTc pertechnetate, and 99mTc RBC labelled "in vivo".
Snarski AM
Eur J Nucl Med; 1989; 15(3):137-42. PubMed ID: 2540983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
